News for CareRx Corporation (CHHHF)

Revenue: $92.8 million in Q3 2024, down from $93.8 million in Q3 2023, but up from $92 million in Q2 2024.Adjusted EBITDA: $7.8 million in Q3 2024, a 6.2% incr

Revenue: $92 million for Q2 2024, down from $94.5 million in Q2 2023, up from $89.7 million in Q1 2024.Adjusted EBITDA: $7.5 million for Q2 2024, up 7% from $7

• • • • • This is an excerpt of the original content. To... | November 9, 2022

Read CareRx (OTCMKTS:CHHHF) Trading 11.9% Higher at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Shares Down 20.3% at ETF Daily News

Read CareRx Co. (OTCMKTS:CHHHF) Short Interest Down 12.5% in August at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Price Target Cut to C$6.00 by Analysts at Desjardins at ETF Daily News

Read Stifel Nicolaus Cuts CareRx (OTCMKTS:CHHHF) Price Target to C$6.50 at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Shares Down 6.1% at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Price Target Lowered to C$8.50 at Desjardins at ETF Daily News

Read CareRx Co. (OTCMKTS:CHHHF) Short Interest Update at ETF Daily News

Read CareRx (OTCMKTS:CHHHF) Price Target Lowered to C$8.00 at Canaccord Genuity Group at ETF Daily News